Zobrazeno 1 - 2
of 2
pro vyhledávání: '"adverse effects [Amyloid beta-Peptides]"'
Autor:
Manuel Mittag, Jens Wagner, Martin K. Schwarz, Martin Fuhrmann, Julia Steffen, Stefanie Poll, Boris Schmidt, Inna Schwarz, Hans-Rüdiger Geis, Stefan Remy, Lena C. Schmid
Publikováno v:
Neuron 92(1), 114-125 (2016). doi:10.1016/j.neuron.2016.08.034
Alzheimer's disease (AD) is characterized by cognitive decline and neuronal network dysfunction, but the underlying mechanisms remain unknown. In the hippocampus, microcircuit activity during learning and memory processes is tightly controlled by O-L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7a786719da20288da0170b4830c12de
https://doi.org/10.1016/j.neuron.2016.08.034
https://doi.org/10.1016/j.neuron.2016.08.034
Publikováno v:
Neurobiology of aging 40, 98-102 (2016). doi:10.1016/j.neurobiolaging.2016.01.008
Soluble forms of oligomeric amyloid beta (AβO) are involved in the loss of synaptic plasticity and memory, especially in early phases of Alzheimer's disease. Stimulation of dopamine D1/D5 receptors (D1R/D5R) is known to increase surface expression o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc4a79b12d8984a4459ae5c63477ca7
https://pubmed.ncbi.nlm.nih.gov/26973108
https://pubmed.ncbi.nlm.nih.gov/26973108